Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for the Prediction of Neoadjuvant Chemotherapy-Insensitive Breast Cancers

PURPOSE: We developed and validated a contrast-enhanced spectral mammography (CESM)-based radiomics nomogram to predict neoadjuvant chemotherapy (NAC)-insensitive breast cancers prior to treatment. METHODS: We enrolled 117 patients with breast cancer who underwent CESM examination and NAC treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhongyi, Lin, Fan, Ma, Heng, Shi, Yinghong, Dong, Jianjun, Yang, Ping, Zhang, Kun, Guo, Na, Zhang, Ran, Cui, Jingjing, Duan, Shaofeng, Mao, Ning, Xie, Haizhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937952/
https://www.ncbi.nlm.nih.gov/pubmed/33692950
http://dx.doi.org/10.3389/fonc.2021.605230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937952/
https://www.ncbi.nlm.nih.gov/pubmed/33692950
http://dx.doi.org/10.3389/fonc.2021.605230

Ejemplares similares